Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Acute Lymphoblastic Leukemia in Children

NCT00165178 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT00165178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00165178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Acute Lymphoblastic Leukemia in Children
Lead sponsor
Dana-Farber Cancer Institute
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2000
Completion date
May 31, 2011
Enrollment
498 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia